A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity
Clinical trial NCT04012255 · TERMINATED
Trial details
- NCT number
- NCT04012255
- Sponsor
- Novo Nordisk A/S
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-15
- Primary completion
- 2019-08-30
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.